Jackson Thornton Asset Management »

Neurocrine Biosciences shares owned by Jackson Thornton Asset Management

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Jackson Thornton Asset Management from 13F filings

Historical chart of Jackson Thornton Asset Management investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Jackson Thornton Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Jackson Thornton Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $469k 3.4k 139.08

More positions owned by Jackson Thornton Asset Management

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust World Ex Us Core (DFAX)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Dimensional Etf Trust Intl Small Cap V (DISV)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Dimensional Etf Trust Short Duration F (DFSD)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
American Centy Etf Tr Intl Smcp Vlu (AVDV)

View all positions for Jackson Thornton Asset Management

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
Dodge & Cox
Jpmorgan Chase & Co
State Street Corporation
AQR Capital Management
Renaissance Technologies
Geode Capital Management
Morgan Stanley
Wellington Management Company
Bellevue Group
Thomas Stevens, CFA"
Deerfield Management Company
Rtw Investments
Millennium Management

View all funds holding Neurocrine Biosciences